ANGLE Device Able To Track Spread Of Breast Cancer, University of Southern California Study
The University of Southern California Norris Comprehensive Cancer Center has been working with the Parsortix device, developed by AIM-listed ANGLE, to harvest circulating tumour cells.
An American study has raised the prospect of a new UK-developed blood test taking the place of painful biopsies in metastatic breast cancer.
The University of Southern California (USC) Norris Comprehensive Cancer Center has been working with the Parsortix device, developed by AIM-listed ANGLE PLC (LON:AGL), to harvest circulating tumour cells.
An American study has raised the prospect of a new UK-developed blood test taking the place of painful biopsies in metastatic breast cancer.
The University of Southern California (USC) Norris Comprehensive Cancer Center has been working with the Parsortix device, developed by AIM-listed ANGLE PLC (LON:AGL), to harvest circulating tumour cells.